U-NBIX

Q:NBIX - NEUROCRINE BIOSCIENCES INC - http://WWW.NEUROCRINE.COM

19:11:53 EDT

Sym-X	Bid - Ask					Last	Chg	%Ch	Vol	$Vol	#Tr	Open-Hi-Lo	Year Hi-Lo	Last Tr	News	Delay
NBIX - Q	0.2	97.03	·	102.00	0.1	101.22	+2.01	2.0	1,104.8	110,834	11,393	99.45 101.53 98.62	129.29 75.25	17:09:05	Mar 21	15 min RT 2¢

Trade times are ET. News times are ET. Bid/ask/vol sizes in thousands.
Nasdaq Indicators -- Market: Nasdaq -- Bid Tick: Down -- UPC Restricted: No

Fundamentals · Holders · Trade Workstation · Market Depth · 3 Month Closes · Technical Charts 1 yr | 2 yr | 3 yr | 5 yr | 10 yr | 15 yr | 20 yr · Live Charts 1 yr | 1 day · 1yr Bulletins · Historical · Options · Portfolio

Recent Trades - Last 10 of 11393

More trades...

Time ET	Ex	Price	Change	Volume
17:09:05	Q	101.22	2.01	18,047
16:12:47	Q	101.22	2.01	13
16:10:29	Q	101.22	2.01	935
16:07:54	Q	101.22	2.01	18
16:07:48	Q	101.22	2.01	66
16:07:27	Q	101.22	2.01	122
16:06:47	Q	99.05	-0.16	1
16:06:45	Q	101.22	2.01	562
16:04:24	Q	101.22	2.01	1,133
16:04:24	Q	101.22	2.01	810

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Date ET	Symbol	Type	Headline
2023-03-21 16:01	U:NBIX	News Release200	Neurocrine Biosciences to Present at the Stifel 2023 CNS Days
2023-03-09 16:30	U:NBIX	News Release200	Neurocrine Biosciences Announces Results from the Real-World RE-KINECT ¢ „ ¢ Study Published in the Journal of Patient-Reported Outcomes Demonstrating the Effects of Possible Tardive Dyskinesia (TD) on Patient Health and Social Functioning
2023-03-09 08:30	U:NBIX	News Release200	Neurocrine Biosciences Presents Data on In Vitro Dissolution Performance of INGREZZA ‚ ® (valbenazine) Capsule Contents via Soft Foods or Feeding Tube at AMDA - PALTC 2023 Annual Conference
2023-03-08 16:01	U:NBIX	News Release200	Neurocrine Biosciences to Participate at Investor Conferences in March

Date ET

Symbol

Type

Headline

2023-03-21 16:01

U:NBIX

News Release

Neurocrine Biosciences to Present at the Stifel 2023 CNS Days

2023-03-09 16:30

U:NBIX

News Release

Neurocrine Biosciences Announces Results from the Real-World RE-KINECT ¢ „ ¢ Study Published in the Journal of Patient-Reported Outcomes Demonstrating the Effects of Possible Tardive Dyskinesia (TD) on Patient Health and Social Functioning